These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28534652)

  • 1. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
    Sutton JA; Clauss RP
    Brain Inj; 2017; 31(8):1019-1027. PubMed ID: 28534652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and brain SPECT scan response to zolpidem in patients after brain damage.
    Nyakale NE; Clauss RP; Nel W; Sathekge M
    Arzneimittelforschung; 2010; 60(4):177-81. PubMed ID: 20486466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans.
    Clauss RP; Nel WH
    Arzneimittelforschung; 2004; 54(10):641-6. PubMed ID: 15553102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications.
    Du B; Shan A; Zhang Y; Zhong X; Chen D; Cai K
    Am J Med Sci; 2014 Mar; 347(3):178-82. PubMed ID: 23462249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: a case report.
    Shames JL; Ring H
    Arch Phys Med Rehabil; 2008 Feb; 89(2):386-8. PubMed ID: 18226667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report.
    Hall SD; Yamawaki N; Fisher AE; Clauss RP; Woodhall GL; Stanford IM
    Clin Neurophysiol; 2010 Apr; 121(4):549-55. PubMed ID: 20097125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics.
    Snyman N; Egan JR; London K; Howman-Giles R; Gill D; Gillis J; Scheinberg A
    Neuropediatrics; 2010 Oct; 41(5):223-7. PubMed ID: 21210338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of metabolism and complexity in the brain of patients with disorders of consciousness.
    Bodart O; Gosseries O; Wannez S; Thibaut A; Annen J; Boly M; Rosanova M; Casali AG; Casarotto S; Tononi G; Massimini M; Laureys S
    Neuroimage Clin; 2017; 14():354-362. PubMed ID: 28239544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.
    Clauss RP; Dormehl IC; Kilian E; Louw WK; Nel WH; Oliver DW
    Arzneimittelforschung; 2002; 52(10):740-4. PubMed ID: 12442636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier integrity in a zolpidem-responder patient.
    Nyakale NE; Clauss RP; Nel HW; Sathekge MM
    S Afr Med J; 2012 Jul; 102(10):790-1. PubMed ID: 23034205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem-Induced Arousal by Paradoxical GABAergic Stimulation: A Case Report With F-18 Flumazenil Positron Emission Tomography and Single Photon Emission Computed Tomography Study.
    Kim C; Kwon BS; Nam KY; Park JW; Lee HJ
    Ann Rehabil Med; 2016 Feb; 40(1):177-81. PubMed ID: 26949686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem.
    Chatelle C; Thibaut A; Gosseries O; Bruno MA; Demertzi A; Bernard C; Hustinx R; Tshibanda L; Bahri MA; Laureys S
    Front Hum Neurosci; 2014; 8():917. PubMed ID: 25520636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolpidem efficacy and safety in disorders of consciousness.
    Machado C; Estévez M; Rodriguez-Rojas R
    Brain Inj; 2018; 32(4):530-531. PubMed ID: 29393689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial.
    Whyte J; Myers R
    Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of cerebral perfusion after zolpidem administration in the baboon model.
    Clauss RP; Dormehl IC; Oliver DW; Nel WH; Kilian E; Louw WK
    Arzneimittelforschung; 2001; 51(8):619-22. PubMed ID: 11556120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.
    Licata SC; Lowen SB; Trksak GH; Maclean RR; Lukas SE
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1645-52. PubMed ID: 21640782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial direct current stimulation effects in disorders of consciousness.
    Angelakis E; Liouta E; Andreadis N; Korfias S; Ktonas P; Stranjalis G; Sakas DE
    Arch Phys Med Rehabil; 2014 Feb; 95(2):283-9. PubMed ID: 24035769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem for the Treatment of Neurologic Disorders: A Systematic Review.
    Bomalaski MN; Claflin ES; Townsend W; Peterson MD
    JAMA Neurol; 2017 Sep; 74(9):1130-1139. PubMed ID: 28655027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cuban perspective on management of persistent vegetative state.
    Machado C; Estévez M; Rodríguez R; Pérez-Nellar J; Gutiérrez J; Carballo M; Olivares A; Fleitas M; Pando A; Beltrán C
    MEDICC Rev; 2012 Jan; 14(1):44-8. PubMed ID: 22334112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury.
    Williams ST; Conte MM; Goldfine AM; Noirhomme Q; Gosseries O; Thonnard M; Beattie B; Hersh J; Katz DI; Victor JD; Laureys S; Schiff ND
    Elife; 2013 Nov; 2():e01157. PubMed ID: 24252875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.